Jardiance 25 mg film-coated tablets clinical trials
5 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
Effects of empagliflozin on plasma glucose in patients with HNF1A-MODY: a randomized, double-blind, crossover trial
This study looks at how a drug called empagliflozin (Jardiance) affects blood sugar in people with a specific type of diabetes called HNF1A-MODY. It compares this drug to a dummy pill (placebo) to see if it helps manage blood sugar levels.
For: Maturity-onset diabetes of the young type 3 (HNF1A-MODY)Denmark - Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Comparative Bioavailability of Empagliflozin 25 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
This study compared two versions of a 25 mg empagliflozin tablet in healthy volunteers. It checked if they delivered the same amount of medicine into the body after a single dose, helping ensure consistent drug effects for patients.
For: No medical conditionPortugal - Ongoing, recruitingTherapeutic use (Phase IV)
Intraclass safety and efficacy comparison among SGLT-2 inhibitors in elderly patients with type 2 diabetes. A pragmatic, phase IV, multicenter, open-label, randomised controlled trial.
This study is looking at how well different diabetes medicines, like Invokana and Forxiga, work and how safe they are for older people with type 2 diabetes. The main goal is to see if these medicines help control blood sugar without causing dangerously low levels.
For: Type 2 diabetes mellitusItaly - Ongoing, recruitingTherapeutic exploratory (Phase II)
Acute effects of SGLT2 inhibitor on kidney allograft oxygen tension: A randomized, double-blind, placebo controlled crossover trial
This study is looking at how a medicine called Jardiance affects oxygen levels in transplanted kidneys. We want to see if it can help these kidneys work better by improving their oxygen supply, using special MRI scans to measure this.
For: Kidney transplant recipientsDenmark - AuthorisedTherapeutic confirmatory (Phase III)
Sodium-glucose cotransporter-2 inhibitors to stABiLizE coronary atherosclerosis pro-gression after acute Myocardial Infarction in women and men with diabetes mellitus
This study looks at how certain diabetes medications, called SGLT2 inhibitors, might affect the build-up of fatty deposits (atherosclerosis) in the heart's arteries after a heart attack. It aims to see if these medicines can slow down or stop this build-up in people with diabetes.
For: Myocardial Infarction · diabetes mellitusItaly